Inventor · disambiguated record
Calla M. Olson
Also filed as: OLSON CALLA · OLSON CALLA M
6 granted patents·3 pending applications·3 citations·filing 2017–2022
68Inventor score
Top patents by PatentIndex Score
9 records- 0178US10865204B2Degradation of cyclin-dependent kinase 4/6 (CDK4/6) by conjugation of CDK4/6 inhibitors with E3 ligase ligand and methods of useDANA FARBER CANCER INST INC·Filed 2017·Granted Dec 15, 2020·3 cites·30 claims
- 0272US11827636B2Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of useDANA FARBER CANCER INST INC·Filed 2021·Granted Nov 28, 2023·0 cites·16 claims
- 0365US11247991B2Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of useDANA FARBER CANCER INST INC·Filed 2020·Granted Feb 15, 2022·0 cites·23 claims
- 0453US10865205B2Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of useDANA FARBER CANCER INST INC·Filed 2017·Granted Dec 15, 2020·0 cites·14 claims
- 0553US2024167074A1Biochemical selectivity profiling against rna helicasesBAYLOR COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 0652US2024159737A1Cellular selectivity profiling against rna helicases and splicing regulatorsBAYLOR COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 0749US12318452B2Degraders of WEE1 kinaseDANA FARBER CANCER INST INC·Filed 2019·Granted Jun 3, 2025·0 cites·19 claims
- 0844US2021340140A1Degradation of cyclin-dependent kinase 4/6 (cdk4/6) by conjugation of cdk4/6 inhibitors with e3 ligase ligand and methods of useDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 0940US10532103B2Degradation of cyclin-dependent kinase 9 (CDK9) by conjugation of CDK9 inhibitors with E3 ligase ligand and methods of useDANA FARBER CANCER INST INC·Filed 2017·Granted Jan 14, 2020·0 cites·23 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →